Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Observational Study of the Effectiveness of Gemcitabine -Docetaxel in Patients With Relapsed Osteosarcoma Who Have Been Treated With HD-IFO in First Line Treatment

NCT04651179 is registered in ClinicalTrials.gov with Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna as lead sponsor.

NCT NCT04651179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04651179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Observational Study of the Effectiveness of Gemcitabine -Docetaxel in Patients With Relapsed Osteosarcoma Who Have Been Treated With HD-IFO in First Line Treatment
Lead sponsor
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Phase
Observational
Overall status
Completed
Start date
April 24, 2020
Completion date
November 23, 2021
Enrollment
33 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

osteosarcoma metastatic, osteosarcoma recurrent